Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler
Public ClinicalTrials.gov record NCT01196104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Open-label, Randomized, Forced-titration Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Insulin Inhalation Powder, Using the Gen2 Inhaler, in Combination With Insulin Glargine Versus Insulin Aspart in Combination With Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Over a 16-week Treatment Period
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, randomized, forced-titration clinical trial evaluating the efficacy and safety of Technosphere Insulin (TI) Inhalation Powder in combination with insulin glargine versus insulin aspart in combination with insulin glargine in subjects with type 2 diabetes.
Study identification
- NCT ID
- NCT01196104
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 39 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Aug 2011 (Actual)
- Completion
- Mar 2012 (Actual)
- Last update posted
- Oct 30, 2014
2010 – 2012
United States locations
- U.S. sites
- 29
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research Inc | Mobile | Alabama | 36608 | — |
| Valley Research | Fresno | California | 93720 | — |
| Health Care Partners Medical Group | Long Beach | California | 90806 | — |
| Diabetes Research Center | Tustin | California | 92780 | — |
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Laureate Clinical Research Group | Atlanta | Georgia | 30308 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30309 | — |
| Alta Pharmaceutical Research Center | Dunwoody | Georgia | 30338 | — |
| John H Stoger Jr Hospital of Cook County | Chicago | Illinois | 60612 | — |
| LaPorte County Institute for Clinical Research Inc. | Michigan City | Indiana | 46360 | — |
| Radiant Research Inc (Minneapolis) | Edina | Minnesota | 55435 | — |
| Amin Radparvar's Private Practice | City of Saint Peters | Missouri | 63376 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Billings Clinic Research Center | Billings | Montana | 59101 | — |
| Creighton Diabetes Center | Omaha | Nebraska | 68131 | — |
| University of New Mexico HCS | Albuquerque | New Mexico | 87131 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| North Shore Diabetes and Endocrine Associates | New Hyde Park | New York | 11042 | — |
| Endocrine Research Physicians East PA | Greenville | North Carolina | 27834 | — |
| Your Diabetes Endocrine Nutrition Group, Inc. | Mentor | Ohio | 44060 | — |
| Legacy Clinical Research | Portland | Oregon | 97232 | — |
| OHSU Diabetes Center Research Oregon Health & Science University | Portland | Oregon | 97239 | — |
| The Endocrine Clinic | Memphis | Tennessee | 38119 | — |
| Dallas Diabetes & Endocrine Center | Dallas | Texas | 75230 | — |
| Baylor Endocrine Center | Dallas | Texas | 75246 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| SAM Clinical Research Center | San Antonio | Texas | 78229 | — |
| Exodus Healthcare Network | Magna | Utah | 84044 | — |
| Diabetes Research Center -Fletcher Allen Health Care | South Burlington | Vermont | 05403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01196104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01196104 live on ClinicalTrials.gov.